GNRC led the downward target revisions today. The consensus average target price fell to $289.56 from $293.94. The power equipment maker carries a $12.1bn market cap and has SI at 4.4% of free float.
Similar pressure hit HUBB and AEE. Hubbell's consensus target slipped to $563.25 from $565.73. Ameren's fell to $118.80 from $119.53. Both remain well-held by buy-side consensus.
The most striking sector move was a wave of recommendation removals across life science tools. DHR, TMO, A, and RVTY all had recommendations pulled simultaneously by the same analyst house. This is a common housekeeping action when a firm drops coverage, but the breadth across the sector is notable.
On the positive side, KIM earned an upgrade. The REIT's consensus shifted to 15 buys from 14, with the average target rising to $26.94. Kimco has a $15.1bn market cap. REITs are drawing fresh attention as rate expectations soften.
CVNA also received a target increase, to $83.31. The used-car platform has seen strong momentum, and SI sits at 8.8% of free float. A higher target from analysts adds to short seller pressure there.
CCL rounded out the upgrades. The cruise operator's target ticked up to $34.03, with 22 analyst buy recommendations intact.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
